Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Nov 15.
Published in final edited form as: Biol Psychiatry. 2014 May 21;76(10):785–793. doi: 10.1016/j.biopsych.2014.04.019

Post-Stress Block of Kappa Opioid Receptors Rescues Long-Term Potentiation of Inhibitory Synapses and Prevents Reinstatement of Cocaine Seeking

Abigail M Polter 1, Rachel A Bishop 1, Lisa A Briand 2, Nicholas M Graziane 1,3, R Christopher Pierce 2, Julie A Kauer 1,*
PMCID: PMC4240751  NIHMSID: NIHMS600441  PMID: 24957331

Abstract

Background

Dopaminergic neurons in the ventral tegmental area (VTA) of the brain are an important site of convergence of drugs and stress. We previously identified a form of long-term potentiation of GABAergic synapses on these neurons (LTPGABA). Our studies have shown that exposure to acute stress blocks this LTP, and that reversal of the block of LTPGABA is correlated with prevention of stress-induced reinstatement of cocaine-seeking.

Methods

Sprague-Dawley rats were subjected to cold-water swim stress. Midbrain slices were prepared following stress, and whole-cell patch clamp recordings of IPSCs were performed from VTA dopamine neurons. Antagonists of glucocorticoid and kappa opioid receptors were administered at varying time points after stress. Additionally, the ability of a post-stress kappa antagonist to block FSS-induced reinstatement of cocaine self-administration was tested.

Results

We report that an acute stressor blocks LTPGABA for five days after stress through a transient activation of glucocorticoid receptors and more lasting contribution of kappa opioid receptors. Pharmacological block of kappa opioid receptors beginning as late as 4 days after stress has occurred can reverse the block of LTPGABA. Furthermore, post-stress administration of a kappa opioid antagonist prevents reinstatement of cocaine-seeking.

Conclusions

Our results show that a brief stressor can cause days-long changes in the reward circuitry and reveal roles for glucocorticoid and kappa opioid receptors as mediators of the lasting effects of stress on synaptic plasticity. These results indicate that kappa opioid receptor antagonists reverse the neuroadaptations underlying stress-induced drug-seeking behavior and may be useful in the treatment of cocaine addiction.

Keywords: Stress, kappa opioid receptor, glucocorticoid receptor, synaptic plasticity, ventral tegmental area, reinstatement

Introduction

Studies utilizing animal models have repeatedly shown that acute or chronic stress escalates intake of addictive drugs (1-5). Moreover, in animals in which cocaine self-administration was extinguished, stress causes reinstatement of drug-seeking behavior (6-11). In particular, acute severe stress increases drug-seeking for several days (11).

These behavioral interactions between stress and drugs of abuse have led to interest in the brain's mesolimbic reward circuitry as a potential locus for stress-induced dysregulation. Within this circuitry, dopamine neurons of the ventral tegmental area (VTA) are important targets of both stress and drugs of abuse (12-17). Although activation of dopamine neurons is classically associated with reward and reinforcement, numerous studies have shown that acute and chronic stressors also enhance dopaminergic function in the mesolimbic system (18-22).

Synapses on dopamine neurons exhibit parallel changes after exposure to stress or to drugs of abuse, suggesting a potential mechanism for the induction of drug-seeking behavior after stress. Many studies have found that excitatory synapses on VTA dopamine neurons are potentiated, as indicated by the ratio of AMPA to NMDA receptors, following exposure to drugs of abuse or by acute stress (23-29). Either in vivo or in vitro administration of the GR agonist dexamethasone increases the AMPA/NMDA ratio, indicating that glucocorticoid receptor activation is sufficient to potentiate these synapses (26).

In addition to these well-documented changes in excitatory synapses, our previous work identified a form of stress-sensitive plasticity of GABAergic synapses on dopamine neurons (LTPGABA) (30, 31). These synapses are potentiated via retrograde signaling of nitric oxide (NO) from the dopamine neuron to a presynaptic GABAergic terminal, leading to a persistent increase GABA release (31, 32). Acute cold water swim stress blocks LTPGABA (25, 30), and we have identified two major pathways that contribute to this block. First, RU486, an antagonist of glucocorticoid receptors (GRs), administered prior to stress prevents the loss of LTPGABA (30). Second, norBNI, an antagonist of κ opioid receptors (κORs), also prevents the block of LTPGABA by stress. Importantly, unlike RU486, which normalizes plasticity of both excitatory and inhibitory synapses (23, 30), norBNI prevents the loss of LTPGABA without preventing the stress-induced increase in AMPA/NMDA ratio at excitatory synapses (25). Concurrently, we found that infusion of norBNI directly into the VTA prevents reinstatement of cocaine-seeking after the same cold water swim stress, suggesting that reinstatement can be prevented without restoring AMPA/NMDA ratios to their pre-stress level (25).

In the current study, we expand on our previous work to investigate the time course of the loss of LTPGABA after stress. We find that acute swim stress prevents LTPGABA for at least five days after stress, and that this is dependent on early activation of glucocorticoid receptors in addition to a prolonged contribution of kappa opioid receptors. Surprisingly, we find that treatment with a κOR antagonist reverses the effects of stress on both GABAergic synaptic plasticity and cocaine-seeking, even at time points considerably after stress has occurred. Together, our results suggest a mechanism by which brief stressors can induce long-lasting changes in synaptic plasticity and in behavior and support a potential target for reversing such neuroadaptations even after the stress has occurred.

Materials and Methods

For detailed methodological information, please see supplementary materials

Animals for slice electrophysiology

All procedures were carried out in accordance with the guidelines of the National Institutes of Health for animal care and use, and were approved by the Brown University Institutional Animal Care and Use Committee.

Acute Forced Swim Stress

Stress was administered by a modified Porsolt forced swim task (FSS) as previously described (23, 30). RU486 (40 mg/kg i.p.) was administered either 60 minutes or 24 hours after FSS. Nor-binaltorphimine (norBNI; 10 mg/kg, i.p.) was administered either two hours, 24 hours, or 4 days after FSS. For corticosterone measurement, serum was isolated from trunk blood and corticosterone levels were determined via EIA.

Self-administration

Self-administration was performed as previously described (25). For self-administration experiments, male Sprague Dawley rats (Taconic) weighing 200-225g at the start of the experiment were individually housed in square plastic cages. All procedures were approved by the University of Pennsylvania Animal Care and Use Committee. Rats were allowed to lever press for cocaine 6 days a week on a FR1 schedule with a time-out of 20 s and a maximum of 30 infusions per session. Once an animal achieved at least 20 infusions of cocaine in a single daily session under the FR1 schedule, the subject was switched to a fixed-ratio 5 (FR5) schedule of reinforcement.

Extinction & Reinstatement

Following 18 days of cocaine self-administration, drug-seeking behavior was extinguished by replacing the cocaine with 0.9% saline. One hour following the final extinction session, animals were exposed to a 3-minute cold-water swim stress. Animals received intraperitoneal (i.p.) injections of either saline or norBNI (10mg/kg) 2 hours following the stress exposure. The reinstatement session, which was identical to the previous extinction sessions, occurred 24 hours after the stress exposure (11).

Preparation of brain slices and electrophysiology

General methods were as previously reported (30). Midbrain slices (250 μm) were prepared from deeply anesthetized Sprague-Dawley rats (30, 31). In all experiments, the extracellular solution was artificial cerebrospinal fluid containing 6,7-dinitroquinoxaline- 2,3-dione (DNQX; 10 μM) and strychnine (1 μM) to block AMPA and glycine receptors. Patch pipettes were filled with a KCl based solution. Dopamine neurons, which comprise about 70% of all VTA neurons, were identified by the presence of a large Ih-current (> 50 pA) during a voltage step from −50 mV to −100 mV. IPSCs were stimulated using a bipolar stimulating electrode in the lateral VTA. LTPGABA was induced by bath application of the NO donor, SNAP (S-nitroso-N-acetylpenicillamine, 400 μM).

Analysis

Data are presented as means ± SEM of the percent change of LTP levels. All n's are the number of animals, unless otherwise noted. Significance was determined using a Student's t-test or an ANOVA with a significance level of p < 0.05, with post-hoc comparisons as noted.

Results

Acute Stress Blocks LTPGABA for at least five days

Our previous studies have shown that acute forced swim stress (FSS) blocks LTPGABA (25, 30), however one outstanding question is how long this effect lasts. To test this, we assayed LTPGABA at varying time points after a single exposure to stress. Dopamine neurons were identified electrophysiologically by the presence of an Ih. In the lateral VTA, where we record, Ih+ dopamine neurons are primarily those that project to the nucleus accumbens (33). However, it has been reported that there are also Ih+ GABAergic neurons (34). Therefore, using this criterion, a subset of the neurons recorded from and reported here may be non-dopaminergic neurons, and there are likely some subtypes of dopamine neurons that are not included in our data. Bath application of the nitric oxide donor, SNAP, robustly potentiated GABAergic synapses onto VTA dopamine neurons in slices from control animals, but not those from animals that had been stressed one day prior to slicing (Figure 1A-1B) (25, 30-32). This block of LTPGABA persisted for at least five days after stress (Figure 1C). By ten days after the stressor, however, LTPGABA was restored (Figure 1D). Thus, a brief, acute stressor promotes a substantial alteration in GABAergic synaptic plasticity that lasts for at least five days, but is not permanent (Figure 1E-F).

Figure 1. Stress blocks LTPGABA for at least five days.

Figure 1

(A) Example experiment showing LTPGABA induced by application of SNAP (black bar) in slices from an unstressed animal. Single experiments demonstrating loss of LTPGABA in slices from animals stressed (B) 24 hours or (C) 5 days prior to slicing. (D) Single experiment showing recovery of LTPGABA measured ten days after stress. (E) Summary graph showing compiled data from all four groups. (F) Comparison of the magnitude of LTPGABA 15-20 minutes after SNAP application. (1-way ANOVA, F3,,31=4.551, p=0.009. IPSC amplitudes, control rats: 142±10% of baseline values, n=14, 24 hours after stress, 90±17% of baseline values, n=5; p < 0.05 from control; 5 days post FSS: 101±13% of baseline, n=8, p<0.05 from control; 10 days post FSS: 137±7% of baseline values, n=8, n.s. from control, Dunnett's Multiple Comparison Test). Insets for this and all figures: IPSCs before (black trace, control) and 15 minutes after drug application (red trace, SNAP, 400 μM). Scale bars: 20 ms, 100 pA. Insets are averages of ten IPCSs.

Glucocorticoids are sufficient to block LTPGABA

What signaling molecules are responsible for maintaining the block of LTPGABA for many days after stress? Our previous studies have indicated that both glucocorticoid receptors (GR) and κ opioid receptors (κOR) contribute to the stress-induced block of LTPGABA. (25, 30), as antagonists of both GRs and κORs prevent the block of LTPGABA by stress when administered in vivo before stress. We set out to investigate the role of these pathways after stress to determine their contribution to the long-term maintenance of the block of LTPGABA.

We first addressed the role of GRs and their endogenous ligand, corticosterone. Previous work has shown that serum corticosterone levels are rapidly increased following swim stress, and return to baseline levels within hours (35). Likewise, we see a robust increase in serum corticosterone concentration one hour following swim stress (Figure 2). As previous studies have shown mixed evidence for whether κORs can regulate the levels of corticosterone, we tested whether κORs were involved in the induction of serum corticosterone by FSS (Figure 2) (36-38). Pre-treatment with norBNI did not have any effect on the FSS-induced increase in corticosterone (Figure 2), indicating that glucocorticoid signaling does not depend on κOR activation. These results are consistent with previous studies indicating that the magnitude of corticosterone release induced by repeated FSS is not affected by norBNI administration and does not differ between WT and prodynorphin null mice (38).

Figure 2. FSS elevates glucocorticoids independently of κOR.

Figure 2

Normalized serum corticosterone concentrations from rats pretreated with norBNI or saline before FSS. Serum was collected 1 hour post FSS (saline-control: 1.00±0.37, n=5; saline-FSS: 42.42±3.92, n=6; norBNI-FSS: 45.18±2.62 n=7; 1-way ANOVA, F2,15=65.42, p<0.0001. *p<0.05 in comparison to control, Tukey's multiple comparison test.

To test whether local glucocorticoid receptor activation is sufficient to block LTPGABA, we applied dexamethasone (dex; 10 μM), a glucocorticoid receptor agonist, or vehicle to midbrain slices from naïve animals for 60 min (Figure 3A). Slices were then washed for at least 60 min in aCSF before recording. As shown in Figure 3B, vehicle-treated slices exhibited characteristic SNAP-induced potentiation. However, GABAergic synapses in slices treated with dexamethasone failed to potentiate (Figure 3B-E). Moreover, dexamethasone itself had no effect on IPSC amplitude in slices from naïve animals (Figure 3F-G). Our data indicate that exposure to stress and subsequent circulation of glucocorticoids could trigger the loss of LTPGABA by acting directly on glucocorticoid receptors within the VTA.

Figure 3. Glucocorticoids are sufficient to block LTPGABA.

Figure 3

(A) Experimental protocol for bath-applied dexamethasone (dex) experiments. (B) Example experiment from a vehicle-treated slice. (C) Example experiment from a vehicle treated slice. (D) Summary of compiled data for DMSO- and dexamethasone-treated slices. (E) Average magnitude of LTP as measured 15-20 minutes after application of SNAP (IPSC amplitudes, DMSO: 167.0±24% of baseline, n=9 cells/8 animals; Dex: 113.3±3% of baseline, n=9 cells/9 animals. *, p<0.05, Student's t-test) (F) Example experiment showing that IPSC amplitudes are unchanged during dexamethasone application (G) Summary of compiled data for bath applied dex (30 minutes after dex application: 108.5±9% of baseline values, n=9, no significant difference from baseline, p=0.36, Student's t-test).

Glucocorticoid receptors play a transient role in the block of LTPGABA

As corticosterone levels are only transiently elevated after FSS, we expected that GRs might have a similarly transient role in maintaining the block of LTPGABA following FSS. To test this idea, we administered the GR receptor antagonist RU486 (40 mg/kg, i.p.) at varying time points after stress, and prepared slices 24 hours after RU486 injection (24-48 hours after FSS) (Figure 4A). As expected, slices from stressed, vehicle-treated animals showed no LTPGABA (Figure 4B). Slices from animals given RU486 one hour after stress exhibited NO-induced LTPGABA (Figure 4C). In slices prepared from animals that were given RU486 24 hours after stress, however, no LTPGABA was elicited (Figure 4D). These results indicate that LTPGABA is rescued when glucocorticoid signaling is blocked shortly after stress, but not 24 hours after stress (Figure 4E-F). These results suggest that glucocorticoid signaling plays an early but transient role in the block of LTPGABA by stress.

Figure 4. Transient effect of glucocorticoids in maintaining the block of LTPGABA.

Figure 4

(A) Experimental design for post-stress RU486 treatment. (B) Example experiment showing absence of LTPGABA in slices from a vehicle-treated stressed animal. (C) Single experiment showing LTPGABA in a slice from an animal treated with RU486 (40 mg/kg in 5%DMSO/canola oil) 1 hr after stress. (D) Single experiment showing RU486 no longer rescues LTPGABA when administered 24 hours after stress. (E) Summary graph showing compiled data from all three groups. (F) Comparison of the magnitude of LTPGABA 15-20 minutes after SNAP application. (1-way ANOVA, F2,24=6.003, p=0.0077. IPSC amplitudes, vehicle-stress: 99±8% of baseline values, n=12, RU486 1 hr post-stress, 141±11% of baseline values, n=8; p<0.05 from control; RU486 24 hours post-stress: 113±8% of baseline, n=7, n.s. from control) Tukey's multiple comparison test.

κORs maintain the block of LTPGABA for multiple days after stress

We next investigated the role of κORs in maintaining the block of LTPGABA after stress. Our previous studies found that activation of κORs in VTA slices is sufficient to block LTPGABA and that treatment with a κOR antagonist before FSS prevents both the loss of LTPGABA and reinstatement of cocaine-seeking (25). We hypothesized that these2 behavioral and physiological changes are due to persistent activation of κORs after stress. To test this, rats were subjected to FSS, and given an injection of the κOR antagonist norBNI (10 mg/kg, i.p.) either two hours, one day, or four days following FSS; slices were prepared for recording 24 hours after norBNI treatment (Figure 5A). Slices from vehicle-treated stressed animals showed no potentiation in response to SNAP (Figure 5B). Treatment with norBNI two hours after stress reversed the block, as SNAP induced LTPGABA (Figure 5C). Remarkably, LTPGABA was rescued in slices from animals treated with norBNI twenty four hours or four days after stress (Figure 5D-5E). These results demonstrate that treatment with a κOR antagonist is capable of reversing stress's effects on plasticity, even when administered well after the stressor itself (Figure 5F-G). κORs therefore play a critical role in maintaining the block of LTPGABA after stress.

Figure 5. Long-term role of κORs in maintaining the block of LTPGABA.

Figure 5

(A) Experimental design for post-stress norBNI treatment. (B) Example experiment showing loss of LTPGABA in slices from a vehicle treated stressed animal. Single experiments showing recovery of LTPGABA in slices from animals treated with norBNI (10 mg/kg i.p.) at 2 hrs(C), 24 hrs (D), or 4 days (E) after stress. (F) Summary graph showing compiled data from all four groups. (G) Comparison of the magnitude of LTPGABA 15-20 minutes after SNAP application. (1-way ANOVA, F3, 60=4.883, p=0.0042. IPSC amplitudes, vehicle-stress: 105±4% of baseline values, n=27, norBNI 2 hr post-stress, 131±7% of baseline values, n=18; p<0.05 from control; norBNI 24 hours post-stress: 138±15% of baseline, n=8, p<0.05 from control, norBNI 4 days post stress: 130±9% of baseline, n=11, p<0.05 from control Dunnett's Multiple Comparison Test).

Treatment with a κOR antagonist after stress prevents reinstatement

Several studies have shown a role for κORs at the intersection between stress and drug-seeking behavior, however few studies have addressed ongoing roles for κORs in promoting drug-seeking after a stressful experience has already occurred. Cold-water forced swim stress is ideal to test this hypothesis, as rats that experience this stress exhibit elevated responding for cocaine for several days after the stressor (11). We recently showed that administration of κOR antagonist twenty-four hours before stress prevents reinstatement of cocaine-seeking measured one day after cold-water swim stress (25). Given that κOR antagonist administration is capable of reversing the loss of LTPGABA when administered after stress, we next tested if it could also prevent reinstatement of cocaine-seeking when administered after stress. We trained rats to self-administer cocaine and then extinguished this behavior (Figure 6A, 6B). Acquisition of self-administration was similar between the two groups of rats, and no significant difference in lever-pressing was seen between groups during the last extinction session (Figure 6B,C). After extinction criteria were met, rats were subjected to a cold water forced swim. Two hours after swim stress, rats were given a single i.p. injection of norBNI. Twenty-two hours later, rats were returned to the operant chamber for the reinstatement session. Vehicle-treated rats showed a robust increase in lever-pressing compared to the final reinstatement session, but norBNI treated animals did not (Figure 6C). These data show that κOR receptor antagonists given after a stressor were highly effective in preventing reinstatement of drug seeking and provide additional correlative evidence linking LTPGABA and drug seeking after stress.

Figure 6. Post-stress norBNI prevents reinstatement of cocaine-seeking.

Figure 6

(A) Experimental design for self-administration, extinction and reinstatement behavioral experiment. Animals were subjected to stress and 2 hours later were given either norBNI (10 mg/kg i.p.) or vehicle. (B) Cocaine self-administration training was not significantly different between the two groups prior to stress and norBNI treatment. Two-way repeated measure ANOVA revealed a significant effect of time (F1, 17=34.23, p<0.05), but no significant effect of group (F1, 17=0.1671) or interaction (F1, 17=0.4725) (C) Reinstatement of cocaine seeking. Lever presses in vehicle (black) and norBNI (white) treated animals during the final extinction session (Ext) and reinstatement session (RI). Two-way ANOVA, interaction, F1, 14=11.29, p=.0047; Sidak's Post-hoc test vehicle vs. norBNI on stress-induced reinstatement, adjusted p=.0002. N= 7 in norBNI group; 9 in vehicle group.

Discussion

Acute stress has lasting effects on plasticity

In this study we show that an acute stressor triggers neuroadaptations of the mesolimbic reward circuitry that lasts for several days. The block of LTPGABA requires a transient activation of GRs and a more persistent contribution of κORs. Although there have been few studies examining long-lasting synaptic consequences of acute stressors in the VTA, other brief experiences can alter plasticity in this region over a similar time scale. For example, a single exposure to cocaine potentiates excitatory synapses on VTA dopamine neurons for seven days (27, 39).

The time course of the block of LTPGABA after forced swim stress closely matches that of reinstatement to cocaine-seeking after the same stressor (11). In this study, rats in which cocaine self-administration was extinguished demonstrated significantly elevated lever-pressing behavior for three days following the stressor, and a trend towards elevated responding four and five days after stress. Although the rats' responding rate converged with that of control animals by five days, when LTPGABA is still completely blocked, it should be noted that the animals were tested daily in the reinstatement task, and thus were simultaneously re-extinguishing their behavior.

GRs and κORs in VTA plasticity and drug seeking

Our results show that the block of LTPGABA is controlled after stress by glucocorticoid and kappa opioid receptors. These results are in line with a growing literature suggesting that κORs and GRs are capable of modulating circuit function of the VTA as well as drug seeking behaviors. GRs are expressed in dopaminergic neurons in the VTA (40, 41), and a GR antagonist blocks potentiation of glutamatergic synapses on VTA dopamine neurons by stress (23, 24, 26). Furthermore, GRs appear to play a role in drug taking, as adrenalectomy (which eliminates endogenous corticosterone) decreases self-administration of cocaine (42). Similarly, GRs are necessary for stress-induced reinstatement of cocaine-seeking (43) and injection of a glucocorticoid is sufficient to induce reinstatement (42). However, it is unclear whether glucocorticoid receptors in the VTA itself are important for these effects. Recent work suggests that glucocorticoid receptors in D1-positive neurons in the nucleus accumbens, but not dopamine neurons themselves are required for cocaine-seeking in unstressed animals (44). To our knowledge, the role of GRs specifically within the VTA itself in stress-induced reinstatement has not been tested.

κORs have emerged as important mediators of the behavioral consequences of stress (45, 46). They also significantly alter neurotransmission within the VTA. In VTA slices, κOR agonists transiently decrease EPSC amplitude on dopaminergic and GABAergic neurons (47), IPSCs on BLA-projecting dopaminergic neurons (48), and dopamine-mediated IPSCs (49). Furthermore, stress-induced reinstatement of cocaine self-administration and conditioned place preference are prevented by κOR antagonist treatment or genetic deletion of κORs or their endogenous ligand, prodynorphin (50-52). Activation of κORs is sufficient to induce reinstatement of place preference to drugs of abuse in unstressed animals (52, 53). Interestingly, while κORs play a significant role in stress-induced reinstatement of both cocaine self-administration and conditioned place preference, these roles may involve distinct circuitry. κORs in a circuit encompassing the dorsal raphe and nucleus accumbens, as well as in the locus coeruleus are crucial for stress-induced reinstatement of place preference (54, 55). However, our recently published work shows that a κOR antagonist administered locally into the VTA prevents reinstatement of cocaine self-administration after cold water swim stress (25), suggesting that κORs in the VTA have a critical role in reinstatement of cocaine self-administration. As mentioned above, κORs have numerous effects in the VTA in addition to blocking LTPGABA (47-49, 56). These effects are generally transient, persisting only as long as the κOR agonist is present, and unlike LTPGABA, it is unknown whether they are altered or on what timescale after stress. However, our data do not preclude the possibility of a persistent upregulation of dynorphin or κOR signaling, which might also modify these other signaling pathways. It is therefore possible that the post-stress effects of norBNI on reinstatement occur independently of the reversal of the blockade of LTPGABA.

Potential mechanisms of long-term alterations in plasticity

By what mechanism is GABAergic plasticity suppressed over several days? Because it remains unknown precisely when LTPGABA begins to be blocked after stress, it is unclear whether administration of RU486 one hour following stress is truly reversing an already established block of LTPGABA or simply preventing a block that has not yet occurred. Nonetheless, by 24 hours after stress, RU486 is not able to reverse the block of LTPGABA, and thus glucocorticoid receptors do not have a significant long-term role in maintaining this block. In contrast, the κOR antagonist norBNI is effective in restoring LTPGABA when administered twenty-four hours or four days following stress, time points when we are certain that the block of LTPGABA is established (Figure 1; (29). Several studies have shown that the corticotrophin-releasing factor type two receptors (CRF2R) induce activation of the dynorphin/κOR system after stress, and recruitment of the CRF2R-κOR pathway is essential for expression of aversive behavioral responses to stress (46, 57). These effects have been suggested to be independent of glucocorticoid signaling (46). The block of LTPGABA by stress, however, requires both GRs and κORs, and the equivalent rise in serum corticosterone following swim stress in both vehicle and norBNI treated animals suggests that activation of GRs occurs upstream of or in parallel with κOR activation (38). These results do not rule out a role for CRF2Rs, and future studies determining what role these receptors play in the block of LTPGABA by stress will be intriguing. Alternatively, the block of LTPGABA by stress may result via signaling events distinct from CRF2R. Glucocorticoids regulate prodynorphin levels in the hippocampus (58), suggesting that a glucocorticoid-mediated upregulation of prodynorphin in VTA-projecting regions such as the BNST or nucleus accumbens could link glucocorticoids and κOR signaling.

Activation of either GRs or κORs in the VTA itself is sufficient to block LTPGABA, as bath application of dexamethasone or the κOR agonist U69593 (25) in vitro prevents SNAP-induced potentiation. The block of LTPGABA could occur through an increase in κOR activation or number, or in κOR-triggered signaling molecules, or a combination of both. Alternatively, GR activation could alter the dynamics of dynorphin release from terminals of neurons from other brain regions. A κOR antagonist delivered into the system would block κORs, negating any of these effects. We cannot rule out, however, that bath application of the κOR or GR agonists block LTPGABA through a distinct mechanism from that occurring after stress in the intact animal, nor that the mechanism of the block immediately after stress differs from the long term maintenance of the block. For example, stress may increase dynorphin levels, as discussed above, or increase the excitability of dynorphin-containing neurons in the nucleus accumbens or BNST that project to the VTA, which would also be functionally prevented by a κOR antagonist.

Downstream effects of loss of LTPGABA

What consequences for VTA functioning might loss of LTP at GABAergic synapses on dopamine neurons have? GABAA receptors exert powerful inhibitory control of VTA dopamine neurons (59-62). Dopamine neurons have relatively depolarized membrane potentials, sitting close to action potential threshold (63). Activation of the GABAA receptor chloride conductance will potently decrease the spontaneous firing that characterizes these neurons, as opening these channels hyperpolarizes dopamine cells below their firing threshold. With the field stimulation used in our experiments, we likely are activating a number of inhibitory projections from several regions known to modulate firing and excitability of dopamine neurons (61, 62, 64-66).

We hypothesize that LTPGABA serves as an activity-dependent “brake” on dopamine neurons. These neurons are critical drivers of reward and aversion (67) and the VTA is a crucial hub in reinstatement and other stress-linked behaviors (68-70). The loss of LTPGABA after stress therefore represents removal of a mechanism for control of dopamine neuron firing. Importantly, this loss persists, even after being separated in time and space from the stressor, providing a mechanism by which a single stressor can cause lasting changes in behavior. This is potentially relevant to the situation in patients, where individuals with substance use disorders may encounter opportunities to relapse in times and contexts that are distinct from stressors they may experience.

Recent work has highlighted distinctions between populations of dopamine neurons in the VTA and demonstrated subclasses of neurons with distinct links to behavioral reward and aversion (67). Accumbens projecting neurons, which are found in the lateral VTA, show an increased AMPA/NMDA ratio after a single cocaine injection, and optogenetic activation of these neurons supports place preference (71, 72). In contrast, PFC-projecting neurons in the medial VTA show an increased AMPA/NMDA ratio in response to an aversive stimulus and optogenetic activation of these neurons induces place aversion (71, 72). Although we did not specifically identify neurons by projection target in this study, our selection criteria for neurons (Ih+ neurons, primarily in the lateral VTA) suggest that we may primarily be recording from accumbens-projecting “reward” neurons (33). If so, our studies reveal a stress-induced alteration in cells associated with reward. Furthermore, while many studies of κORs have focused on specifically aversive processes, our work may indicate a role for κORs in the reward-promoting subcircuitry of the VTA.

It is important to note that electrophysiological studies in this work were conducted using young, cocaine-naïve animals. This is an important caveat, as development and exposure to drugs of abuse both cause changes throughout the brain. Although work is still needed to guarantee that the signaling mechanisms are similar in young and adult animals, our previous studies show that LTPGABA can be induced in adult rats following cocaine self-administration and extinction (25). This indicates that the mechanism for induction of LTPGABA is intact in adult animals, that it is not blocked or occluded by long-term exposure to cocaine, and that it is available to be blocked by stress.

Intervention to prevent reinstatement after stress

As discussed above, κORs play a significant role in addictive and stress-related disorders (46, 73-76). Human studies have implicated polymorphisms in the dynorphin gene as a risk factor for cocaine dependence (77-79). Furthermore, expression of the prodynorphin gene is higher in individuals with a history of psychostimulant abuse, although it is unclear whether this represents a cause or an effect of exposure to drugs of abuse (80). Our studies suggest that ongoing processes such as stress-induced dysregulation of κOR signaling and neuroplasticity could contribute to the natural course of addiction.

Most importantly, our studies indicate that stress-induced neuroadaptations can be reversed. Treatment with a κOR antagonist reversed the stress-induced block of LTPGABA, even when administered four days after stress. Using this information, we also showed that administration of norBNI after stress also prevented reinstatement of drug-seeking. These data strengthen the association between κORs and stress-induced drug seeking and raise the possibility that further study of LTPGABA may yield a similarly rich vein of potential pharmacological targets.

Supplementary Material

01

Acknowledgments

This research was supported by NIH grants DA011289 (JAK), MH019118 (NMG and AMP), AA007459 (AMP), DA033372 (LAB), DA15214 (RCP), DA22339 (RCP), DA33641 (RCP), DA18678 (RCP) and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation (AMP). The authors thank members of the Kauer and Pierce laboratories for helpful comments on this manuscript.

Footnotes

Financial Disclosure: The authors report no biomedical financial interests or potential conflict of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Piazza PV, Deminiere JM, le Moal M, Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain research. 1990;514:22–26. doi: 10.1016/0006-8993(90)90431-a. [DOI] [PubMed] [Google Scholar]
  • 2.Ramsey NF, Van Ree JM. Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain research. 1993;608:216–222. doi: 10.1016/0006-8993(93)91461-z. [DOI] [PubMed] [Google Scholar]
  • 3.Goeders NE, Guerin GF. Non-contingent electric footshock facilitates the acquisition of intravenous cocaine self-administration in rats. Psychopharmacology. 1994;114:63–70. doi: 10.1007/BF02245445. [DOI] [PubMed] [Google Scholar]
  • 4.Shaham Y, Stewart J. Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology. 1994;114:523–527. doi: 10.1007/BF02249346. [DOI] [PubMed] [Google Scholar]
  • 5.Haney M, Maccari S, Le Moal M, Simon H, Piazza PV. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain research. 1995;698:46–52. doi: 10.1016/0006-8993(95)00788-r. [DOI] [PubMed] [Google Scholar]
  • 6.Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology. 2003;168:3–20. doi: 10.1007/s00213-002-1224-x. [DOI] [PubMed] [Google Scholar]
  • 7.Le AD, Quan B, Juzytch W, Fletcher PJ, Joharchi N, Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology. 1998;135:169–174. doi: 10.1007/s002130050498. [DOI] [PubMed] [Google Scholar]
  • 8.Shaham Y, Rodaros D, Stewart J. Reinstatement of heroin-reinforced behavior following long-term extinction: implications for the treatment of relapse to drug taking. Behavioural pharmacology. 1994;5:360–364. doi: 10.1097/00008877-199406000-00015. [DOI] [PubMed] [Google Scholar]
  • 9.Erb S, Shaham Y, Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology. 1996;128:408–412. doi: 10.1007/s002130050150. [DOI] [PubMed] [Google Scholar]
  • 10.Shaham Y, Stewart J. Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology. 1995;119:334–341. doi: 10.1007/BF02246300. [DOI] [PubMed] [Google Scholar]
  • 11.Conrad K, James EM, Lindsay MC, Kerstin AF, Mitch B, Michela M. Persistent Increases in Cocaine-Seeking Behavior After Acute Exposure to Cold Swim Stress. Biological psychiatry. 2010;68:303–305. doi: 10.1016/j.biopsych.2010.03.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Fields HL, Hjelmstad GO, Margolis EB, Nicola SM. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annual review of neuroscience. 2007;30:289–316. doi: 10.1146/annurev.neuro.30.051606.094341. [DOI] [PubMed] [Google Scholar]
  • 13.Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nature reviews Neuroscience. 2007;8:844–858. doi: 10.1038/nrn2234. [DOI] [PubMed] [Google Scholar]
  • 14.Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2010;35:217–238. doi: 10.1038/npp.2009.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wise RA, Morales M. A ventral tegmental CRF-glutamate-dopamine interaction in addiction. Brain research. 2010;1314:38–43. doi: 10.1016/j.brainres.2009.09.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Luscher C, Malenka RC. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron. 2011;69:650–663. doi: 10.1016/j.neuron.2011.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Polter AM, Kauer JA. Stress and VTA synapses: implications for addiction and depression. The European journal of neuroscience. 2014;39:1179–1188. doi: 10.1111/ejn.12490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tidey JW, Miczek KA. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain research. 1996;721:140–149. doi: 10.1016/0006-8993(96)00159-x. [DOI] [PubMed] [Google Scholar]
  • 19.Anstrom KK, Woodward DJ. Restraint increases dopaminergic burst firing in awake rats. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2005;30:1832–1840. doi: 10.1038/sj.npp.1300730. [DOI] [PubMed] [Google Scholar]
  • 20.Ungless MA, Argilli E, Bonci A. Effects of stress and aversion on dopamine neurons: implications for addiction. Neuroscience and biobehavioral reviews. 2010;35:151–156. doi: 10.1016/j.neubiorev.2010.04.006. [DOI] [PubMed] [Google Scholar]
  • 21.Brischoux F, Chakraborty S, Brierley DI, Ungless MA. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:4894–4899. doi: 10.1073/pnas.0811507106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864–868. doi: 10.1126/science.1120972. [DOI] [PubMed] [Google Scholar]
  • 23.Saal D, Dong Y, Bonci A, Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003;37:577–582. doi: 10.1016/s0896-6273(03)00021-7. [DOI] [PubMed] [Google Scholar]
  • 24.Dong Y, Saal D, Thomas M, Faust R, Bonci A, Robinson T, et al. Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(−/−) mice. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:14282–14287. doi: 10.1073/pnas.0401553101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Graziane NM, Polter AM, Briand LA, Pierce RC, Kauer JA. Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron. 2013;77:942–954. doi: 10.1016/j.neuron.2012.12.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Daftary SS, Panksepp J, Dong Y, Saal DB. Stress-induced, glucocorticoid-dependent strengthening of glutamatergic synaptic transmission in midbrain dopamine neurons. Neuroscience letters. 2009;452:273–276. doi: 10.1016/j.neulet.2009.01.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 2001;411:583–587. doi: 10.1038/35079077. [DOI] [PubMed] [Google Scholar]
  • 28.Bellone C, Luscher C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nature neuroscience. 2006;9:636–641. doi: 10.1038/nn1682. [DOI] [PubMed] [Google Scholar]
  • 29.Chen BT, Bowers MS, Martin M, Hopf FW, Guillory AM, Carelli RM, et al. Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron. 2008;59:288–297. doi: 10.1016/j.neuron.2008.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Niehaus J, Murali M, Kauer J. Drugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area. Eur J Neurosci. 2010;32:108–117. doi: 10.1111/j.1460-9568.2010.07256.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nugent F, Penick E, Kauer J. Opioids block long-term potentiation of inhibitory synapses. Nature. 2007;446:1086–1090. doi: 10.1038/nature05726. [DOI] [PubMed] [Google Scholar]
  • 32.Nugent FS, Niehaus JL, Kauer JA. PKG and PKA signaling in LTP at GABAergic synapses. Neuropsychopharmacology. 2009;34:1829–1842. doi: 10.1038/npp.2009.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron. 2008;57:760–773. doi: 10.1016/j.neuron.2008.01.022. [DOI] [PubMed] [Google Scholar]
  • 34.Margolis EB, Lock H, Hjelmstad GO, Fields HL. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? The Journal of physiology. 2006;577:907–924. doi: 10.1113/jphysiol.2006.117069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jain S, Bruot BC, Stevenson JR. Cold swim stress leads to enhanced splenocyte responsiveness to concanavalin A, decreased serum testosterone, and increased serum corticosterone, glucose, and protein. Life sciences. 1996;59:209–218. doi: 10.1016/0024-3205(96)00286-x. [DOI] [PubMed] [Google Scholar]
  • 36.Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H, et al. Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2009;34:775–785. doi: 10.1038/npp.2008.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Bilkei-Gorzo A, Racz I, Michel K, Mauer D, Zimmer A, Klingmuller D, et al. Control of hormonal stress reactivity by the endogenous opioid system. Psychoneuroendocrinology. 2008;33:425–436. doi: 10.1016/j.psyneuen.2007.12.010. [DOI] [PubMed] [Google Scholar]
  • 38.McLaughliN JP, Land BB, Li S, Pintar JE, Chavkin C. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2006;31:787–794. doi: 10.1038/sj.npp.1300860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Borgland SL, Malenka RC, Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2004;24:7482–7490. doi: 10.1523/JNEUROSCI.1312-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstrom AC, et al. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proceedings of the National Academy of Sciences of the United States of America. 1986;83:9779–9783. doi: 10.1073/pnas.83.24.9779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hensleigh E, Pritchard LM. Glucocorticoid receptor expression and sub-cellular localization in dopamine neurons of the rat midbrain. Neuroscience letters. 2013;556:191–195. doi: 10.1016/j.neulet.2013.09.067. [DOI] [PubMed] [Google Scholar]
  • 42.Deroche V, Marinelli M, Le Moal M, Piazza PV. Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. The Journal of pharmacology and experimental therapeutics. 1997;281:1401–1407. [PubMed] [Google Scholar]
  • 43.Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1997;17:2605–2614. doi: 10.1523/JNEUROSCI.17-07-02605.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ambroggi F, Turiault M, Milet A, Deroche-Gamonet V, Parnaudeau S, Balado E, et al. Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nature neuroscience. 2009;12:247–249. doi: 10.1038/nn.2282. [DOI] [PubMed] [Google Scholar]
  • 45.Van't Veer A, Carlezon WA., Jr Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology. 2013;229:435–452. doi: 10.1007/s00213-013-3195-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bruchas MR, Land BB, Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain research. 2010;1314:44–55. doi: 10.1016/j.brainres.2009.08.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Margolis EB, Hjelmstad GO, Bonci A, Fields HL. Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. Journal of neurophysiology. 2005;93:3086–3093. doi: 10.1152/jn.00855.2004. [DOI] [PubMed] [Google Scholar]
  • 48.Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006;26:2788–2797. doi: 10.1523/JNEUROSCI.4331-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ford CP, Beckstead MJ, Williams JT. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. Journal of neurophysiology. 2007;97:883–891. doi: 10.1152/jn.00963.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Beardsley P, Howard J, Shelton K, Carroll F. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology. 2005;183:118–126. doi: 10.1007/s00213-005-0167-4. [DOI] [PubMed] [Google Scholar]
  • 51.Carey A, Borozny K, Aldrich J, McLaughlin J. Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur J Pharmacol. 2007;569:84–89. doi: 10.1016/j.ejphar.2007.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Redila V, Chavkin C. Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology. 2008;200:59–70. doi: 10.1007/s00213-008-1122-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Sperling RE, Gomes SM, Sypek EI, Carey AN, McLaughlin JP. Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration. Psychopharmacology. 2010;210:199–209. doi: 10.1007/s00213-010-1844-5. [DOI] [PubMed] [Google Scholar]
  • 54.Al-Hasani R, McCall JG, Foshage AM, Bruchas MR. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2013;38:2484–2497. doi: 10.1038/npp.2013.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:19168–19173. doi: 10.1073/pnas.0910705106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:2938–2942. doi: 10.1073/pnas.0511159103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2008;28:407–414. doi: 10.1523/JNEUROSCI.4458-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Watanabe Y, Akabayashi A, McEwen BS. Adrenal steroid regulation of neuropeptide Y (NPY) mRNA: differences between dentate hilus and locus coeruleus and arcuate nucleus. Brain research Molecular brain research. 1995;28:135–140. doi: 10.1016/0169-328x(94)00192-h. [DOI] [PubMed] [Google Scholar]
  • 59.Paladini CA, Tepper JM. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo. Synapse. 1999;32:165–176. doi: 10.1002/(SICI)1098-2396(19990601)32:3<165::AID-SYN3>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  • 60.Johnson SW, North RA. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. The Journal of physiology. 1992;450:455–468. doi: 10.1113/jphysiol.1992.sp019136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Tan KR, Yvon C, Turiault M, Mirzabekov JJ, Doehner J, Labouebe G, et al. GABA neurons of the VTA drive conditioned place aversion. Neuron. 2012;73:1173–1183. doi: 10.1016/j.neuron.2012.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.van Zessen R, Phillips JL, Budygin EA, Stuber GD. Activation of VTA GABA neurons disrupts reward consumption. Neuron. 2012;73:1184–1194. doi: 10.1016/j.neuron.2012.02.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Grace AA, Onn SP. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1989;9:3463–3481. doi: 10.1523/JNEUROSCI.09-10-03463.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2012;37:1164–1176. doi: 10.1038/npp.2011.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Matsui A, Williams JT. Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2011;31:17729–17735. doi: 10.1523/JNEUROSCI.4570-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, et al. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013;496:224–228. doi: 10.1038/nature12041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Lammel S, Lim BK, Malenka RC. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology. 2013 doi: 10.1016/j.neuropharm.2013.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.McFarland K, Davidge SB, Lapish CC, Kalivas PW. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2004;24:1551–1560. doi: 10.1523/JNEUROSCI.4177-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Nestler EJ, Carlezon WA., Jr The mesolimbic dopamine reward circuit in depression. Biological psychiatry. 2006;59:1151–1159. doi: 10.1016/j.biopsych.2005.09.018. [DOI] [PubMed] [Google Scholar]
  • 70.Briand LA, Vassoler FM, Pierce RC, Valentino RJ, Blendy JA. Ventral tegmental afferents in stress-induced reinstatement: the role of cAMP response element-binding protein. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30:16149–16159. doi: 10.1523/JNEUROSCI.2827-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Lammel S, Ion DI, Roeper J, Malenka RC. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron. 2011;70:855–862. doi: 10.1016/j.neuron.2011.03.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature. 2012;491:212–217. doi: 10.1038/nature11527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Kreek MJ, Zhou Y, Butelman ER, Levran O. Opiate and cocaine addiction: from bench to clinic and back to the bench. Curr Opin Pharmacol. 2009;9:74–80. doi: 10.1016/j.coph.2008.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Shippenberg TS. The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders? Neuropsychopharmacology. 2009;34:247. doi: 10.1038/npp.2008.165. [DOI] [PubMed] [Google Scholar]
  • 75.Wee S, Koob GF. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 2010;210:121–135. doi: 10.1007/s00213-010-1825-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Smith JS, Schindler AG, Martinelli E, Gustin RM, Bruchas MR, Chavkin C. Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci. 2012;32:1488–1495. doi: 10.1523/JNEUROSCI.2980-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Chen AC, LaForge KS, Ho A, McHugh PF, Kellogg S, Bell K, et al. Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am J Med Genet. 2002;114:429–435. doi: 10.1002/ajmg.10362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Dahl JP, Weller AE, Kampman KM, Oslin DW, Lohoff FW, Ferraro TN, et al. Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence. Am J Med Genet B Neuropsychiatr Genet. 2005;139B:106–108. doi: 10.1002/ajmg.b.30238. [DOI] [PubMed] [Google Scholar]
  • 79.Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J, et al. Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence. Addict Biol. 2007;12:496–502. doi: 10.1111/j.1369-1600.2007.00069.x. [DOI] [PubMed] [Google Scholar]
  • 80.Hurd YL, Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 1993;13:357–369. doi: 10.1002/syn.890130408. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES